Welcome to our dedicated page for DANAHER /DE/ SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DANAHER /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DANAHER /DE/'s regulatory disclosures and financial reporting.
Danaher Corporation has agreed to acquire Masimo Corporation, a specialty diagnostics and patient monitoring company, in an all-cash deal. Danaher will pay $180 per Masimo share, implying a total enterprise value of about $9.9 billion including assumed debt and net of acquired cash.
The price represents roughly an 18x multiple of Masimo’s estimated 2027 EBITDA, or about 15x when including the full benefit of expected annual synergies. Masimo is expected to generate more than $530 million of EBITDA in 2027, with over $125 million in annual cost synergies and more than $50 million in annual revenue synergies by the fifth full year after closing.
Danaher expects the deal to add $0.15–$0.20 to adjusted diluted EPS in the first full year and about $0.70 by the fifth year. Masimo will operate as a standalone business within Danaher’s Diagnostics segment. The transaction is anticipated to close in the second half of 2026, funded with cash on hand and new debt, and remains subject to Masimo stockholder approval and customary regulatory clearances, including U.S. and non-U.S. antitrust and foreign investment reviews.
Danaher Corporation reported that director Jessica L. Mega has retired from its Board of Directors effective February 5, 2026. She stepped down because of commitments related to her other professional obligations.
The company stated that Dr. Mega’s decision was not due to any disagreement with Danaher regarding its operations, policies, or practices, indicating an orderly and amicable board transition.
Danaher Corporation Executive Vice President Christopher Paul Riley acquired 1,046 shares of common stock on February 4, 2026 at a price of $0 per share. The shares were delivered upon achievement of performance criteria for performance stock units granted on February 24, 2023 under the Danaher Corporation 2007 Omnibus Incentive Plan.
The award remains subject to a holding period that continues through December 31, 2027. Following this transaction, Riley directly beneficially owns 15,585 shares of Danaher common stock.
Danaher Corporation reported that Senior Vice President Brian W. Ellis acquired 1,695 shares of common stock on February 4, 2026. The shares were issued at $0 per share following the Compensation Committee’s determination that performance criteria from a February 24, 2023 performance stock unit award were achieved under the Danaher Corporation 2007 Omnibus Incentive Plan.
After this award, Ellis directly holds 14,994 shares of Danaher common stock. The award remains subject to a holding period that continues through December 31, 2027, meaning the shares must be held until at least that date.
Danaher Corporation executive Jose-Carlos Gutierrez-Ramos reported the vesting of 1,695 shares of common stock. The shares were acquired on February 4, 2026 at a price of $0.00 per share following achievement of performance criteria under a 2023 performance stock unit award.
After this transaction, he beneficially owned 12,999 shares of Danaher common stock in direct form. The vested award remains subject to a holding period that continues through December 31, 2027, meaning the shares are restricted from sale until that date.
Danaher Corporation reported an insider equity award for SVP of Human Resources, Georgeann Couchara. On February 4, 2026, she acquired 1,413 shares of common stock at $0 per share, following the achievement of performance criteria tied to earlier granted performance stock units.
These units were originally awarded on February 24, 2023 under the Danaher Corporation 2007 Omnibus Incentive Plan. The resulting shares are subject to a holding period that continues through December 31, 2027. After this transaction, Couchara beneficially owns 4,038 shares of Danaher common stock directly.
Danaher Corporation Executive Vice President Julie A. Sawyer Montgomery reported an equity award tied to prior performance. On February 4, 2026, she acquired 848 shares of Danaher common stock at $0 per share, following the Compensation Committee’s determination that performance criteria for earlier-granted performance stock units were achieved.
After this transaction, she beneficially owns 17,501 shares of Danaher common stock in direct ownership. The award remains subject to a holding period that runs through December 31, 2027, meaning the shares are restricted until that date under the company’s incentive plan terms.
Danaher Corporation President & CEO Rainer Blair reported the acquisition of 8,474 shares of common stock on February 4, 2026 at a price of $0. These shares resulted from performance stock units granted in 2023 after the compensation committee determined the performance criteria were achieved.
Following this transaction, Blair directly owns 20,422 common shares and indirectly owns 58,255 shares through a trust. The award remains subject to a holding period that continues through December 31, 2027, meaning the shares must be held until that date.
Danaher Corporation reported an insider share award for its EVP & Chief Financial Officer, Matthew McGrew. On February 4, 2026, he acquired 2,684 shares of common stock at $0, following the Compensation Committee’s determination that performance criteria for previously granted performance stock units had been achieved.
The performance stock units were originally awarded on February 24, 2023 under the Danaher Corporation 2007 Omnibus Incentive Plan and remain subject to a holding period through December 31, 2027. After this transaction, McGrew directly owned 20,890 common shares and indirectly held 10,232.549 shares through a 401(k) plan.
Danaher Corporation Executive Vice President Gregory M. Milosevich reported an award of common stock under a long-term incentive plan. On February 4, 2026, he acquired 679 shares of Danaher common stock at $0 per share, tied to previously granted performance stock units.
The Compensation Committee determined that the performance criteria for a February 24, 2023 award had been achieved, triggering this share delivery. The award remains subject to a holding period through December 31, 2027. Following the transaction, Milosevich beneficially owns 5,099 shares of Danaher common stock directly.